the future of mpn treatment: exciting agents and targets being investigated
Published 2 years ago • 952 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
2:40
the future treatment and management of mpns
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
2:29
future treatment strategies for mpns
-
1:49
advances in the science and treatment of mpns
-
1:54
the potential role of cellular therapies and vaccines in the future treatment of mpns
-
2:43
the management of advanced phase mpns
-
1:00
what's next for mpn?
-
3:21
looking beyond jak inhibitors: novel targeted therapies and strategies for mpn treatment
-
45:36
panel discussion | marketing 2.0 conference
-
7:18
how might luspatercept benefit patients with myelofibrosis?
-
13:48
understanding treatment options for et, pv, and myelofibrosis
-
1:26
the future of jak inhibition for mpns
-
0:59
investigating jak2v617f as a therapeutic target in mpns
-
0:48
promising therapeutic targets in mpns
-
1:56
ongoing and future trials in mpn-ap/bp
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:50
beacon trial results: safety & efficacy of bitopertin in adults with epp
-
4:23
newer treatment options in pv and how the therapeutic landscape is evolving
-
1:43
ruxolitinib’s place in the future treatment landscape for mpns
-
1:23
insights into the management and treatment of accelerated/blast-phase mpns